DuPont (NYSE:DD) today announced the launch of DuPont™ Liveo™ Pharma TPE Overmolded Assemblies, engineered for ultrapure fluid transfer across upstream and downstream pharmaceutical and ...
REDDING, Calif., Aug. 14, 2024 /PRNewswire/ -- According to a new market research report titled, 'Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis ...
The latest addition to the AseptiQuik G line of sterile connectors is BPA-free and made of durable, lightweight polyphenylsulfone (PPSU), which is compatible with both gamma and autoclave ...
DOWNERS GROVE, Ill., Jan. 29, 2025 /PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical processing, ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
The Global Downstream Processing Market is projected to grow at a CAGR of 6.8% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market ...
DOWNERS GROVE, Ill., Sept. 11, 2024 /PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical processing, ...
WILMINGTON, Del., April 1, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has launched DuPont ™ Liveo ™ Pharma TPE Ultra-Low Temp Tubing, a new thermoplastic elastomer tubing designed to ...
Applying smart, continuous manufacturing to biopharmaceuticals ultimately requires detailed digital models for each unit operation. Although the industry is moving toward that goal, achieving ...
DuPont de Nemours, Inc. DD recently announced the launch of its Liveo Pharma TPE Ultra-Low Temp Tubing, a new thermoplastic elastomer tubing. This product has been designed keeping in mind the ability ...
Among the many steps and technologies required in bioprocessing, some of the most expensive ones might be surprising. For instance, one economic analysis of the biopharmaceutical market reported that ...